RUSSELL P. HAGER, Ph.D., M.D.; EDWARD J. HEITZMAN, M.D.; RAYMOND M. YOUNG, Ph.D.
Enterococcus endocarditis has been shown to be particularly resistant to treatment. Of the unsuccessfully treated cases of bacterial endocarditis, the most frequent resistant organisms have been noted to be enterococci.1 Clark, Bryner and Rantz2 have stated that enterococci always tolerate higher penicillin concentrations than other streptococci, and although most species of streptococci occurring in this type infection are inhibited by 0.1 unit of penicillin per ml. of culture medium, the enterococci require over 0.5 unit and occasionally up to 50 to 100 units, the majority being inhibited by between 5 and 10 units. In order to attain therapeutic blood concentrations,
RUSSELL P. HAGER, EDWARD J. HEITZMAN, RAYMOND M. YOUNG. PENICILLIN-CARONAMIDE THERAPY OF ENTEROCOCCUS ENDOCARDITIS(PENICILLIN-CARONAMIDE THERAPY OF ENTEROCOCCUS ENDOCARDITIS*). Ann Intern Med. 1951;34:510–516. doi: 10.7326/0003-4819-34-2-510
Download citation file:
Published: Ann Intern Med. 1951;34(2):510-516.
Cardiology, Endocarditis, Infectious Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use